Morgan Stanley Forecasts Strong Price Appreciation for Molina Healthcare (NYSE:MOH) Stock

Molina Healthcare (NYSE:MOH) had its target price raised by analysts at Morgan Stanley from $167.00 to $192.00 in a research note issued on Friday, Benzinga reports. The firm currently has an “equal weight” rating on the stock. Morgan Stanley‘s price target indicates a potential downside of 9.70% from the company’s current price.

A number of other equities research analysts have also commented on MOH. Sanford C. Bernstein set a $286.00 price target on Molina Healthcare in a research report on Monday, July 13th. Jefferies Financial Group reissued a “hold” rating and set a $220.00 price target on shares of Molina Healthcare in a research report on Friday. Barclays cut their price target on shares of Molina Healthcare from $180.00 to $178.00 and set an “underweight” rating on the stock in a research note on Friday. Robert W. Baird set a $198.00 target price on shares of Molina Healthcare in a research note on Friday. Finally, Zacks Research cut Molina Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, October 12th. Three research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $209.62.

Molina Healthcare Stock Down 1.9%

Shares of MOH traded down $4.01 during trading hours on Friday, hitting $212.63. 516,290 shares of the company were exchanged, compared to its average volume of 1,282,323. The company has a market cap of $11.10 billion, a PE ratio of -1,186.18, a PEG ratio of 30.81 and a beta of 0.78. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.68 and a current ratio of 1.68. The firm’s 50 day moving average is $200.71 and its 200-day moving average is $196.06. Molina Healthcare has a 52 week low of $121.06 and a 52 week high of $244.89.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, October 21st. The company reported $0.89 EPS for the quarter, beating analysts’ consensus estimates of $0.79 by $0.10. The company had revenue of $11.08 billion for the quarter, compared to analyst estimates of $10.86 billion. Molina Healthcare had a negative net margin of 0.11% and a positive return on equity of 2.51%. The company’s quarterly revenue was down 3.4% compared to the same quarter last year. During the same quarter last year, the firm posted $1.84 earnings per share. On average, equities research analysts forecast that Molina Healthcare will post 5.28 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in MOH. RWC Asset Management LLP bought a new position in Molina Healthcare in the third quarter valued at $372,000. Inspire Investing LLC raised its holdings in Molina Healthcare by 19.7% during the third quarter. Inspire Investing LLC now owns 11,291 shares of the company’s stock worth $2,135,000 after acquiring an additional 1,856 shares in the last quarter. MBL Wealth LLC raised its holdings in Molina Healthcare by 49.7% during the third quarter. MBL Wealth LLC now owns 2,297 shares of the company’s stock worth $434,000 after acquiring an additional 763 shares in the last quarter. Root Financial Partners LLC bought a new stake in Molina Healthcare during the third quarter worth about $153,000. Finally, Quadrant Capital Group LLC boosted its position in Molina Healthcare by 4.3% during the third quarter. Quadrant Capital Group LLC now owns 1,960 shares of the company’s stock valued at $411,000 after purchasing an additional 80 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Key Headlines Impacting Molina Healthcare

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Quarterly results exceeded estimates: Molina reported third-quarter adjusted EPS of $0.89 versus the $0.79 consensus estimate, while revenue of $11.08 billion topped expectations of $10.86 billion. Molina Surpasses Q3 Earnings and Revenue Estimates
• Positive Sentiment: Longer-term outlook offers support: Management outlined 2027 premium revenue of at least $45 billion, with potential EPS building blocks totaling more than $9.50. Investors may view this as evidence that recent contract and product issues could be addressed over time. Molina 2027 Outlook
• Neutral Sentiment: 2026 guidance is essentially in line: Molina updated full-year 2026 EPS guidance to approximately $5.25, compared with the consensus estimate of $5.26. The limited change provides little near-term upside surprise but may reduce uncertainty around the year’s results.
• Negative Sentiment: Profitability deteriorated materially: Third-quarter net income fell to $38 million from $79 million a year earlier, while GAAP diluted EPS declined to $0.73 from $1.51. Premium revenue also fell 4% year over year, and membership declined to approximately 4.9 million. Molina Posts Lower Third-Quarter Profit and Revenue
• Negative Sentiment: Medical-cost pressure remains a concern: The medical care ratio increased to 92.9% from 92.6%, reinforcing investor concerns about Medicaid margins, the Florida Medicaid contract’s implementation costs and underperformance in the Medicare Advantage Part D business. Molina Earnings Call Highlights

About Molina Healthcare

Molina Healthcare, Inc is a managed-care company that provides health insurance and related services primarily through government-sponsored programs. Its offerings include Medicaid, Medicare, Medicare-Medicaid dual-eligible plans and health plans sold through government marketplaces under the Affordable Care Act.

The company’s services generally include medical care coordination, behavioral health support, pharmacy benefits and, depending on the plan and state, dental and vision benefits.